Literature DB >> 24102975

The reasons behind variation in Gleason grading of prostatic biopsies: areas of agreement and misconception among 266 European pathologists.

Daniel M Berney1, Ferran Algaba, Philippe Camparo, Eva Compérat, David Griffiths, Glen Kristiansen, Antonio Lopez-Beltran, Rodolfo Montironi, Murali Varma, Lars Egevad.   

Abstract

AIMS: The Gleason scoring system underwent revision at the International Society of Urological Pathology (ISUP) conference in 2005. It is not known how uropathologists have interpreted its recommendations. METHOD AND
RESULTS: A web-based survey to European Network of Uropathology members received replies from 266 pathologists in 22 countries. Eighty-nine per cent claimed to follow ISUP recommendations. Key areas of disagreement included the following. Smoothly rounded cribriform glands were assigned Gleason pattern (GP) 3 by 51% and GP 4 by 49%. Necrosis was diagnosed as GP 5 by 62%. Any amount of secondary pattern of higher grade in needle biopsies was included in the Gleason score by 58%. Tertiary GP of higher grade on needle biopsies was included in the Gleason score by only 58%. If biopsy cores were embedded separately, only 56% would give a Gleason score for each core/slide examined; 68% would give a concluding Gleason score and the most common method was a global Gleason score (77%). Among those who blocked multiple biopsy cores together, 46% would only give an overall Gleason score for the case.
CONCLUSION: Misinterpretation of ISUP 2005 is widespread, and may explain the variation in Gleason scoring seen. Clarity and uniformity in teaching ISUP 2005 recommendations is necessary.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Gleason; ISUP; grading; prostate cancer; survey

Mesh:

Year:  2013        PMID: 24102975     DOI: 10.1111/his.12284

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  20 in total

1.  Multi-objective Parameter Auto-tuning for Tissue Image Segmentation Workflows.

Authors:  Luis F R Taveira; Tahsin Kurc; Alba C M A Melo; Jun Kong; Erich Bremer; Joel H Saltz; George Teodoro
Journal:  J Digit Imaging       Date:  2019-06       Impact factor: 4.056

Review 2.  [Focal therapy for prostate cancer in Germany - 2014 status].

Authors:  A Roosen; R Ganzer; B Hadaschik; J Köllermann; A Blana; T Henkel; A-B Liehr; D Baumunk; S Machtens; G Salomon; L Sentker; U Witsch; K U Köhrmann; M Schostak
Journal:  Urologe A       Date:  2014-07       Impact factor: 0.639

3.  Handling and reporting of transperineal template prostate biopsy in Europe: a web-based survey by the European Network of Uropathology (ENUP).

Authors:  Solene-Florence Kammerer-Jacquet; Eva Compérat; Lars Egevad; Ondra Hes; Jon Oxley; Murali Varma; Glen Kristiansen; Daniel M Berney
Journal:  Virchows Arch       Date:  2018-01-11       Impact factor: 4.064

4.  Target prostate biopsies: How best to report in synoptic format?

Authors:  Michelle R Downes; John R Srigley; Andrew Loblaw; Nathan Perlis; Sangeet Ghai; Theodorus van der Kwast
Journal:  Can Urol Assoc J       Date:  2022-04       Impact factor: 1.862

5.  [Objective grading of prostate carcinoma based on fractal dimensions: Gleason 3 + 4= 7a ≠ Gleason 4 + 3 =7b].

Authors:  P Waliszewski; F Wagenlehner; S Kribus; W Schafhauser; W Weidner; S Gattenlöhner
Journal:  Urologe A       Date:  2014-10       Impact factor: 0.639

6.  Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists.

Authors:  D M Berney; F Algaba; P Camparo; E Compérat; D Griffiths; G Kristiansen; A Lopez-Beltran; R Montironi; M Varma; L Egevad
Journal:  Virchows Arch       Date:  2014-03-04       Impact factor: 4.064

7.  The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.

Authors:  Burkhard Helpap; Daniel Ringli; Jens Tonhauser; Immanuel Poser; Jürgen Breul; Heidrun Gevensleben; Hans-Helge Seifert
Journal:  Pathol Oncol Res       Date:  2015-11-12       Impact factor: 3.201

8.  Prognostic implications of 2005 Gleason grade modification. Population-based study of biochemical recurrence following radical prostatectomy.

Authors:  Frederik B Thomsen; Yasin Folkvaljon; Klaus Brasso; Stacy Loeb; David Robinson; Lars Egevad; Pär Stattin
Journal:  J Surg Oncol       Date:  2016-08-11       Impact factor: 3.454

9.  Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome.

Authors:  Daniel M Berney; Luis Beltran; Gabrielle Fisher; Bernard V North; David Greenberg; Henrik Møller; Geraldine Soosay; Peter Scardino; Jack Cuzick
Journal:  Br J Cancer       Date:  2016-04-21       Impact factor: 7.640

Review 10.  Prevalence of incidental prostate cancer: A systematic review of autopsy studies.

Authors:  Katy J L Bell; Chris Del Mar; Gordon Wright; James Dickinson; Paul Glasziou
Journal:  Int J Cancer       Date:  2015-04-21       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.